Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
UPB is expected to report earnings to fall 8.22% to -67 cents per share on November 04
Q3'26
Est.
$-0.67
Q2'26
Beat
by $0.16
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.06
The last earnings report on August 11 showed earnings per share of -73 cents, beating the estimate of -88 cents. With 839.30K shares outstanding, the current market capitalization sits at 163.77M.